TOGO Meditech Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series B1
  • (Cancelled)

  • Latest Deal Amount
  • $27.8M

  • Investors
  • 3

TOGO Meditech General Information

Description

Developer of medical devices, new biological materials, drugs and other products designed for bioartificial livers. The company has the ability to produce standard human hepatoblasts in medium-scale batches, and has established a large-scale GMP standard culture system.

Contact Information

Website
www.whtogo.com
Formerly Known As
Wuhan Tongqian Biotechnology Co., Ltd.
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5th Floor, Building C4, Bio City
  • No. 666 Gaoxin Avenue, East Lake High-tech Development Zone
  • Wuhan, Hubei 430000
  • China
+86 027
Primary Industry
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • 5th Floor, Building C4, Bio City
  • No. 666 Gaoxin Avenue, East Lake High-tech Development Zone
  • Wuhan, Hubei 430000
  • China
+86 027

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TOGO Meditech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B1) 03-Nov-2022 $27.8M Cancelled Generating Revenue
3. Later Stage VC (Series B) 29-Jul-2022 Completed Generating Revenue
2. Early Stage VC (Series A1) 01-Sep-2018 $2.92M $5.21M Completed Generating Revenue
1. Early Stage VC (Series A) 04-Mar-2016 $2.29M $2.29M Completed Generating Revenue
To view TOGO Meditech’s complete valuation and funding history, request access »

TOGO Meditech Patents

TOGO Meditech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10485916-B2 Bioartificial liver device Active 29-Jul-2016
US-20180117236-A1 Bioartificial liver device Active 29-Jul-2016
WO-2018018792-A1 Four-in-one on-line monitoring and constant-temperature heating integrated system of plush type for bioartificial liver Inactive 29-Jul-2016
US-10493195-B2 Integrated on-line monitoring and thermostatic heating apparatus for bioartificial liver device Active 29-Jul-2016
US-20180117235-A1 Integrated on-line monitoring and thermostatic heating apparatus for bioartificial liver device Active 29-Jul-2016 A61M1/3489
To view TOGO Meditech’s complete patent history, request access »

TOGO Meditech Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
TopoScend Capital Growth/Expansion Minority
Holley Group Corporation Minority
Yili Capital Growth/Expansion Minority
To view TOGO Meditech’s complete investors history, request access »

TOGO Meditech FAQs

  • When was TOGO Meditech founded?

    TOGO Meditech was founded in 2013.

  • Where is TOGO Meditech headquartered?

    TOGO Meditech is headquartered in Wuhan, China.

  • What industry is TOGO Meditech in?

    TOGO Meditech’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is TOGO Meditech a private or public company?

    TOGO Meditech is a Private company.

  • What is TOGO Meditech’s current revenue?

    The current revenue for TOGO Meditech is .

  • How much funding has TOGO Meditech raised over time?

    TOGO Meditech has raised $14.1M.

  • Who are TOGO Meditech’s investors?

    TopoScend Capital, Holley Group, and Yili Capital have invested in TOGO Meditech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process